Kaitlyn D’Onofrio

DocwireNews

A very small percentage of the population carries pathogenic variants that significantly increase their risk for certain cancers and cardiovascular disease. And according to new research, this increased risk was not reliably detected by family history.Lead study author Aniruddh Patel, MD, a cardiology fellow at MGH and Harvard Medical School, said <a href="https://www.eurekalert.org/pub_releases/2020-05/mgh-fhm050120.php">in a press release</a> that the study idea came about to determine &ldquo;how outcomes were affected for pathogenic variant carriers within the context of contemporary care.&rdquo;The researchers assessed three genomic conditions: familial hypercholesterolemia, hereditary breast and <a href="https://www.docwirenews.com/docwire-pick/hem-onc-picks/a-simple-blood-test-to-improve-ovarian-cancer-diagnosis/">ovarian cancer syndrome</a>, and Lynch syndrome. They collected gene-sequencing data from 49,738 patients spanning 22 sites in the UK from the UK Biobank. Data were collected between March 21, 2006, and Oct. 1, 2010, and included inpatient hospital data (dating back to 1977), cancer registry data (dating back to 1957), and death registry data (dating back to 2006). The primary exposures were pathogenic or likely pathogenic DNA variants, as classified by a clinical laboratory geneticist. The main outcome measure was the composite end point specific to each condition: atherosclerotic cardiovascular disease events for familial hypercholesterolemia, breast or ovarian cancer for hereditary breast and ovarian cancer syndrome, and colorectal or uterine cancer for Lynch syndrome.<h2>Pathogenic Variants Increase Disease Risks</h2>A total of 49,738 patients were included (mean age, 57 years; 55% were female), of whom 441 (0.9%) had a pathogenic or likely pathogenic variant associated with one of the three genomic conditions: familial hypercholesterolemia, n=131 (0.3%); hereditary breast and <a href="https://www.docwirenews.com/uncategorized/olaparib-plus-bevacizumab-effective-maintenance-therapy-in-ovarian-cancer/">ovarian</a> cancer syndrome, n=235 (0.5%); and Lynch syndrome, n=76 (0.2%). Patients with the variants had a greater risk for the associated disease: familial hypercholesterolemia, 21.4% of carriers versus 9.4% of noncarriers developed atherosclerotic cardiovascular disease; hereditary breast and ovarian cancer syndrome, 27.6% of female carriers versus 7.7% of female noncarriers developed associated cancers; and Lynch syndrome, 22.4% of carriers versus 1.9% of noncarriers developed colorectal or uterine cancer. At age 75 years, carriers receiving contemporary clinical care had a predicted probability of 45.3% for familial hypercholesterolemia, 41.1% for hereditary breast and ovarian cancer syndrome, and 38.3% for Lynch syndrome. For all three conditions, 39.7% of carriers versus 23.2% of noncarriers reported a family history of the disease.The study was published in <a href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2765072">JAMA Network Open</a>.According to senior author Amit V. Khera, MD, a medical director of the MGH Preventive Genomics Clinic and leader of a research group at MGH and the Broad Institute of MIT and Harvard, &ldquo;What was really striking was that simply taking a family history&mdash;as I currently do in my clinical practice&mdash;would have failed to identify most of the high-risk individuals.&rdquo;&ldquo;Genetic testing is currently used predominantly in those already affected by disease, but these data really speak to the potential of doing it in much broader populations,&rdquo; lead author Dr. Patel said.

Jordana Jampel

Positive Preliminary Results From Phase 1 Trial of Dopaminergic Neuron Graft for Parkinson’s Disease

Dementia

Bradley Warady, MD

Joel M. Topf, MD, FACP

2025 Hume Award Winner Is Dedicated to Children’s Care

NKF Spring Clinical Meetings 2025

Distant Brain Metastases in Cutaneous Melanoma May Be Mitigated With Multiple Pathway Inhibitors

Melanoma

Latest News

All In The Family? History Does Not Identify Patients At High Risk of Cancer, CVD Caused by Pathogenic Variants

Cardiology

A very small percentage of the population carries pathogenic variants that significantly increase their risk for certain cancers and cardiovascular disease. And according to ...

All In The Family? History Does Not Identify Patients At High Risk of Cancer, CVD Caused by

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe